Estrogen has been shown to influence several brain functions as well as the expression of neuropsychiatric diseases. To date, two estrogen receptor (ER) subtypes have been identified, ER␣ and ER␤. ER␣ messenger ribonucleic acid (mRNA) distribution in the human forebrain was recently characterized, and the highest expression was found in restricted areas of the amygdala and hypothalamus. However, no information exists with regard to ER␤ mRNA distribution in the human brain. To this end, the anatomical distribution pattern of ER␤ mRNA expression in the human forebrain was investigated in the present study. Overall, the ER␤ mRNA hybridization signal was relatively low, but the most abundant ER␤ mRNA areas were the hippocampal formation (primarily the subiculum), claustrum, and cerebral cortex; expression was also present in the subthalamic nucleus and thalamus (ventral lateral nucleus). In contrast to ER␣ (studied on adjacent brain sections), ER␤ mRNA expression was low in the hypothalamus and amygdala. Based on the revealed anatomical distribution of the human ER␤ gene expression, a putative role for ER␤ in the modulation of cognition, memory, and motor functions is suggested. (J Clin Endocrinol Metab 85: 3840 -3846, 2000) 
I
N THE BRAIN, estrogen is suggested to regulate and affect not only neuroendocrine events related to reproduction, but also other brain functions, such as mood, memory, and cognition (1) (2) (3) . In addition, estrogens are suggested to influence the expression of several psychiatric and neurological disorders, such as schizophrenia, affective disorders, and Alzheimer's disease (4 -6) .
The effects of estrogens were thought for many years to be mediated by a single estrogen receptor (ER), the ER␣. However, recently, a new ER subtype, ER␤, was discovered and cloned from rat prostate (7) . Several ER␤ isoforms with differences in the ligand-binding domain (8, 9) or putative different lengths of the N-terminus (10) have since been reported. The ERs belong to the nuclear receptor superfamily together with other steroid hormone, thyroid, retinoid, and vitamin D receptors that act as ligand-activated transcription factors (11) . The two ER subtypes are transcribed from two distinct genes (12) and are poorly conserved in the Nterminal region, but have 95% homology in the DNA-binding domain and 55% homology in the ligand-binding domain (7) . When the hormone binds to the receptors, they dimerize and modulate transcription of target genes by binding to specific estrogen response elements on DNA (11, 13) . Moreover, several studies have shown that the two ER subtypes not only form homodimers, but also can dimerize as ER␣/ ER␤ heterodimers (14, 15) . ER␤ appears to bind estrogens in a similar manner as ER␣ (16) even though nonsteroidal ligands with pronounced subtype-selective differences in binding and transcriptional modulatory potency or efficacy have been reported recently (17, 18) .
The specific functions of the different ERs are as yet undetermined. Anatomical studies have helped in part to provide insight into the possible functional role of the ERs. In the rat brain, the ER␣ and ER␤ genes exhibit distinct expression patterns, although they are both predominantly expressed in limbic-related structures (19 -21) . The ER␤ messenger ribonucleic acid (mRNA) expression is dominant within the paraventricular and supraoptic nucleus of the hypothalamus and is often coexpressed with oxytocin or vasopressin (22, 23) . Other ER␤ dominant areas in the rat brain are the hippocampus and the cerebral cortex (19) , which indicate a possible role of ER␤ in memory and cognition. ER␣ mRNA expression, on the other hand, is dominant in the ventromedial hypothalamus and the arcuate nucleus (19, 20) , areas highly involved in reproductive functions. In addition, a critical role for ER␣ in regulating the hypothalamic-pituitary gonadal axis has been confirmed in transgenic mice with a disrupted ER␣ gene (24, 25) .
Based on rat studies, it appears that there is a correlation between the distribution pattern of ER␣ mRNA expression (19, 20) and immunoreactivity (26) , but in the human brain there are technical difficulties in studying ER protein distribution; thus, mRNA studies currently provide the only opportunity to understand the anatomical organization of the human ER neuronal system. Although studies of low expressing mRNA in postmortem human tissue are challenging, we have been able to characterize the anatomical expression pattern of the ER␣ mRNA in the human forebrain (27) . In general, the distribution is comparable to that in the rat, but some species differences exist. For example, ER␣ mRNA expression in the supraoptic and paraventricular nuclei is relatively high in contrast to that in the rat. Little is known about the discrete ER␤ distribution in the primate brain, but ER␤ mRNA has been detected in the hypothalamus and hippocampus of the monkey brain by the use of RT-PCR (28) .
To extend our knowledge of the ER system in the human brain, the present study was performed to characterize the discrete distribution pattern of ER␤ mRNA expression in the human forebrain. The study was focused on structures within the temporal lobe, a brain area relevant for psychiatric disorders and cognitive functions. To dissociate the discrete anatomical organization of ER␤ mRNA expression, in situ hybridization histochemistry was used on postmortem human brain sections. Adjacent brain sections were processed simultaneously for analyses of the ER␣ mRNA expression. As ER␣ mRNA expression has already been mapped in the human brain (27) , the purpose of this study was not to recharacterize the ER␣ mRNA distribution. Instead, ER␣ mRNA detection was performed so that the ER␣ and ER␤ systems could be more easily compared, and the anatomical profiles of the different ER subtypes delineated.
Materials and Methods

Brain tissues
Human brain specimens were obtained at autopsy at the Forensic Medicine Department of Semmelweis University (Hungary) under the guidelines approved by the Semmelweis University human ethical committee. Demographic information for the subjects studied is presented in Table 1 . The brains were immediately cut into 1.5-cm-thick coronal slabs, frozen in dry ice-cooled isopentane, and stored at Ϫ40 C. The slabs were subsequently cut into coronal blocks of tissue at different rostrocaudal levels of the temporal lobe. Within these specimens, the cerebral cortex, amygdala, hypothalamus, and hippocampus were present. A striatal level was also examined. Twenty-micron-thick coronal cryosections were taken throughout the rostral to caudal extent in a cryostat (Jung-Frigocut 2800E cryostat, Leica Corp., Nusslock, Germany) and were thaw-mounted onto SuperFrost Plus glass slides (Brain Research Laboratories, Boston, MA) and then stored at Ϫ30 C. Before in situ hybridization histochemistry experiments, the brain sections were fixed according to following procedure. Sections were brought to room temperature and fixed in 4% paraformaldehyde in 1 ϫ phosphate-buffered saline (pH 7.4) for 5 min, rinsed twice in 1 ϫ phosphate-buffered saline, and once in a TEA buffer (0.1 mol/L triethanolamine and 0.9% NaCl, pH 8.0). This was followed by a 10-min treatment with 0.25% acetic anhydride in TEA buffer and a rinse in 2 ϫ SSC (standard saline citrate). Sections were then processed in a graded series of ethanol (70%, 80%, 95%, and 100%; 1 min) and chloroform (5 min), followed by 100% (1 min) and 95% (1 min) ethanol washes and were subsequently air-dried.
In situ hybridization histochemistry
Chemicals used in the hybridization procedure were purchased mainly from Sigma (St. Louis, MO), [ 33 P]UTP was obtained from NEN Life Science Products (Boston, MA), and enzymes were purchased from Life Technologies, Inc. (Renfrewshire, Scotland). To achieve subtypeselective riboprobes, the complementary DNA (cDNA) sequences for the different plasmid constructions were chosen from areas with low sequence similarities to the other ER subtype or any other known human cDNA sequences. A 308-bp fragment (corresponding to nucleotides 6 -314 GenBank accession no. X99101) of the human ER␤ cDNA (29) , encoding the N-terminal part of the receptor was subcloned into the SacII-PstI linker sites in a Bluescript KS I plasmid (Stratagene, La Jolla, CA). This riboprobe should also be able to detect recently reported isoforms of ER␤ (8 -10).
33 P-Labeled antisense and sense riboprobes against the human ER␤ mRNA were generated by transcription with T3 and T7 polymerase from SacII-and PstI-linearized plasmids, respectively. An ER␤-specific riboprobe directed against the hinge region of the receptor was also constructed. A 195-bp fragment of the human ER␤ cDNA (corresponding to nucleotides 533-732 GenBank accession no. X99101) was subcloned into the linker of a Bluescript KS I plasmid. This plasmid was linearized with KpnI or BamHI, and 33 P-labeled antisense or sense probes were generated with T7 or T3 polymerase, respectively. For detection of human ER␣ mRNA, a 609-bp fragment, nucleotides 162-771 (accession no. M12674) from the human ER␣ cDNA (provided by Karo Bio AB, Huddinge, Sweden) was subcloned into the EcoRV site of a Bluescript KS I plasmid (Stratagene). The subcloned cDNA fragment covers part of the untranslated region and the sequence corresponding to the A/B domain of the receptor. 33 P-Labeled antisense and sense riboprobes against the ER␣ mRNA were generated by transcription with T3 and T7 polymerases from EcoRI-and HindIII-linearized plasmids, respectively. The labeled riboprobes were then separated from unincorporated nucleotides using microspin columns (S-200 HR, Pharmacia Biotech, Stockholm, Sweden).
In situ hybridization histochemistry conditions to detect low expressing human ER␣ mRNA were optimized as described previously (27) , and the same protocol was applied for human ER␤ mRNA analyses. In brief, the riboprobe hybridization was carried out as follows. Heatdenatured 33 P-labeled riboprobes were added to the hybridization cocktail (50% formamide, 0.5 mg sheared salmon sperm DNA, 0.25 mg yeast transfer RNA, 1 ϫ Denhardt's solution, 4 ϫ SSC, and 200 mmol/L dithiothreitol) to a final concentration of 2000 cpm/mm 2 , and 270 L were applied to each section. The sections were coverslipped to prevent evaporation, and the hybridization was carried out in a humidified chamber overnight at 65 C. After hybridization, the sections were rinsed in 2 ϫ SSC followed by ribonuclease A treatment (40 g/mL) for 30 min at 37 C. The sections were then washed in graded series of SSC (2 ϫ, 10 min; 1 ϫ, 10 min; 0.5 ϫ, 10 min; 0.1 ϫ/50% formamide, 1 h, at 48 C; 0.1 ϫ, 1 h, at 53 C) containing 1 mmol/L dithiothreitol, all at room temperature except for the formamide and 0.1 ϫ SSC washes. Subsequently, the sections were dehydrated with ethanol containing 300 mmol/L ammonium acetate. The slides were then air-dried and exposed to Amersham Pharmacia Biotech ␤-max Hyperfilm with 14 C-labeled standards for 5 weeks. Brain sections were scanned (ScanMaker III, Microtek, USA, Adobe PhotoShop, San Jose, CA) at 500 dpi and analyzed in conjunction with human atlases (30, 31) and various published sources (32) (33) (34) .
Results
In addition to the N-terminal antisense riboprobe, a different ER␤-specific antisense riboprobe (directed against the corresponding hinge region of the receptor) was run alone or in combination with the N-terminal riboprobe. The hinge probe produced a similar pattern as the N-terminal probe, but the hybridization signals were weaker due to the shorter probe length (data not shown). When both riboprobes were mixed, the signal to noise ratio decreased due to an apparent increase in the total radioactivity applied on the section. Therefore, only the N-terminal probe was used in the final in situ hybridization protocol for detecting ER␤ mRNA. The corresponding sense probes were run as controls on adjacent brain sections. The ER␤ sense probe showed no labeling (Fig.  1) . As previously described (27) , the ER␣ sense probe showed widespread nonspecific labeling, but the labeling was very different from the distinct hybridization pattern observed with the ER␣ antisense probe that was restricted to discrete brain areas. Although the same hybridization pattern was observed in all subjects, there were small variations in the intensity of the ER␤ and ER␣ hybridization signals between the subjects, but this was not directly associated with the postmortem interval or the sex or age of the subjects. Distinct distribution patterns for ER␤ and ER␣ mRNA were detected in the human forebrain. Both the ER␤ and ER␣ hybridization signals were restricted to a few areas in the human forebrain.
The ER␤ hybridization signals were overall relatively low, but the highest signals were found in the hippocampal formation, claustrum, thalamus, and cerebral cortex ( Table 2) . Consistent with previous findings (27) , the most abundant ER␣ mRNA expression was found in the amygdala and hypothalamus ( Table 2) . The ER mRNA expression described below reflects the relative hybridization signals observed in all of the subjects studied. In the amygdala, the ER␤ mRNA expression pattern was markedly different from that of ER␣ (Fig. 2) . The ER␤ mRNA hybridization signal in the basal and lateral nuclei varied among the subjects, but in most cases the signal was low to moderate. In the posterior cortical amygdala and amygdala-hippocampal area, low ER␤ mRNA expression was observed. The hybridization signals in the periamygdaloid cortex, accessory basal amygdala, medial nucleus, and central nucleus were barely detectable. Similar to the ER␣, ER␤ mRNA expression was found in low levels in the sublenticular substantia innominata, consistent with the nucleus basalis of Meynert (Fig. 3) .
A heterogeneous expression of ER␤ mRNA was evident in the hippocampal formation. The subiculum was one of the most abundant ER␤ mRNA-expressing areas of the forebrain regions examined (Fig. 2, B and C, and Fig. 4) . ER␤ labeling was low in the CA1-CA2 and dentate gyrus and moderate in CA3.
In the temporal cortex, moderate ER␤ mRNA expression was detected, but with a different expression pattern from that for the ER␣ mRNA. ER␤ mRNA labeling was found in deeper cortical laminae (V-VI) compared to the ER␣ mRNA signals that were predominantly evident in only one distinct layer (V; Fig. 2 , B, C, E, and F). Moderate ER␤ mRNA expression was also found in the entorhinal cortex and gyrus ambiens, primarily in the deepest laminae (Figs. 1, 2 , A and B, and 3).
In contrast to hypothalamic mRNA expression of the ER␣ subtype, ER␤ mRNA expression was found in very low levels in the supraoptic and paraventricular nucleus, and even lower hybridization signals levels were evident in the ventromedial hypothalamic nucleus and the arcuate nucleus (Fig. 3) . Of the hypothalamic levels examined, no positive signals were found in the dorsomedial hypothalamic nucleus, anterior hypothalamic area, or mammillary body.
No hybridization signals were observed in the basal gan- glia forebrain regions examined (globus pallidus, caudate nucleus, and putamen; Fig. 3 ), except for the subthalamic nucleus ( Fig. 1) , which expressed low to moderate ER␤ mRNA levels. In the thalamus, low to moderate ER␤ mRNA expression was detected in the ventral lateral nucleus (Fig. 1) .
Moderate ER␤ hybridization signals were also evident in the claustrum (Fig. 2, A-C) .
Discussion
The present study shows that ER␤ has a distinct mRNA distribution pattern from that of ER␣ in the human forebrain. The hippocampal formation (primarily the subiculum), entorhinal cortex, thalamus, and claustrum were the predominant ER␤ mRNA-expressing areas. In contrast, the most abundant expression of ER␣ mRNA is within the hypothalamus and amygdala (current study and Ref. 27 ).
The expression of ER␤ mRNA in the hippocampal formation, entorhinal cortex, and temporal cortex suggests that ER␤ might regulate gene transcription in neuronal populations involved in cognition and memory. The entorhinal cortex and subiculum receive major inputs from sensory cortexes and exhibit prominent efferent (via the perforant path) and afferent connections, respectively, with the hippocampal proper (35, 36) . The cortical areas surrounding the hippocampus, including the entorhinal cortex, have been shown to play an important role in declarative memory in experimental lesion studies in monkeys (35) . The interest in estrogenic effects in cognition and memory has increased during recent years, and there are several reports in both humans and rats showing improved learning and memory after estrogen treatment (37) (38) (39) . The underlying mechanisms are not clear, but estradiol has been found to increase the density of synapses on dendritic spines of the hippocampal CA1 pyramidal cells (40) as well as to increase the sensitivity of these cells to NMDA (N-methyl-d-aspartate) receptor-mediated synaptic input (41) . By administering estradiol after training for a memory task, it has also been shown that estrogen enhances memory storage processes in a time-dependent manner (42) . The memory-enhancing effect of estradiol was blocked by the muscarinic receptor antagonist scopolamine, suggesting that estradiol interacts with cholinergic systems in memory modulation. Furthermore, epidemiological studies have shown that estrogen replacement therapy in postmenopausal women reduces the risk and delays the onset of Alzheimer's disease (6, 43) . Based on the findings of the present study, it could be hypothesized that the ER␤ has a substantial influence on the hippocampal memory-enhancing properties of estrogen in humans.
It is important to emphasize that there are different aspects of cognition and memory, and the ER subtypes might play different roles in various components of these behavioral functions. As the ER␣ mRNA was also present in cognitive and memory-related areas, the role of ER␣ (maybe in combination with ER␤) in cognition and memory cannot be diminished. In fact, the amygdala is known to be critical for certain forms of attention and associative and emotional memories (44, 45) , and ER␣ mRNA was expressed in relatively high levels in this brain area.
The presence of ER␤ mRNA in the ventral lateral thalamus suggests that the ER␤ subtype might modulate information flow to cortical motor areas. Positive estrogenic effects have been observed on motor behaviors such as tardive dyskinesia and dyskinetic episodes in patients treated with neuroleptics and l-DOPA, respectively (46) . ER␤ mRNA expression (low) was found in the subthalamic nucleus, a brain region known to be important for dyskinetic behaviors. However, no detectable expression of the ER␤ gene was found in the striatum or globus pallidus, core structures of the basal ganglia.
Based on the current results showing very low ER␤, but relatively high ER␣, mRNA expression in the human hypothalamus, it can be hypothesized that the estrogen regulation of procreative and autonomic neuroendocrine functions in the human brain is primarily by the ER␣. This finding is consistent with previous studies that have shown that ER␣ a Relative signal intensity from film autoradiograms. Six levels were defined within the detectable range: lowest, just above background; highest, the most intense signal observed. Ϫ, Not detectable; Ϫ/ϩ, barely detectable; ϩ, very weak; ϩ(ϩ), between ϩ and ϩϩ; ϩϩ, weak; ϩϩϩ, moderate; ϩϩϩϩ, strong; ϩϩϩϩϩ, very strong. Signal intensity can be compared between brain regions, but not between the probes. knockout female and male mice are infertile (47, 48) , whereas mice lacking the ER␤ subtype are fertile and exhibit normal sexual behavior (but have fewer and smaller litters compared to wild-type mice due to reduced ovarian efficiency) (49) .
When comparing the present results with previously published data regarding the ER␤ mRNA distribution in other species (19, 20, 50) , many similarities, but also some discrepancies, are apparent. Consistent with the current findings, a previous study reported positive RT-PCR signals in the monkey hippocampus and hypothalamus, although that study did not delineate the anatomical ER␤ mRNA distribution between specific nuclei of these regions (28) . In contrast to the rat and sheep, ER␤ mRNA expression in the supraoptic and paraventricular nucleus in the human brain was very weak, but, as previously shown in humans (27) , relatively moderate to high ER␣ mRNA expression was present in these hypothalamic nuclei, regions that express no or very low ER␣ mRNA in the rat (19, 20) . Considering the present results, it is possible that the ER␣ through evolution might have replaced some previously ER␤-mediated functions. In contrast to the high ER␤ mRNA expression found in the medial posterodorsal amygdala nucleus of the rat, the ER␤ mRNA in the human medial amygdala was barely detectable. In the cerebral cortex, ER␤ mRNA was expressed in layer V in both humans and rats. However, in humans, ER␤ mRNA expression was also found in the deepest cortical layer (VI), whereas in the rat, additional expression was detected in layer IV. Consistent with the rat, however, the hippocampal formation, entorhinal cortex, and thalamus were found to express ER␤ mRNA. Thus, the most marked species differences in brain ER␤ mRNA expression were observed in discrete neuronal populations of the hypothalamus and amygdala as well as in the cerebral cortex. These apparent discrepancies might relate to differences between the human and the rat in reproductive, emotive, and cognitive processing and in the regulation by estrogen of these species-specific functions.
In summary, of the ER subtypes, ER␤ appears to dominate in human hippocampal formation, entorhinal cortex, and thalamus, which suggests a putative role for the ␤-subtype in cognition, nonemotional memory, and motor functions. In contrast, the human amygdala and hypothalamus appear to be ER␣ dominant areas, suggesting that the ␣-subtype modulates neuronal populations involved in emotional interpretation and processing and reproductive and autonomic en- docrine functions. Based on our increasing knowledge about the different neuroanatomical localizations and functions of the two ER subtypes, future subtype-selective ligands may be developed and enable estrogen therapy with more specific targets. Furthermore, now that we know the anatomical organization of the ER␣ and ER␤ in the human brain, it is of interest to evaluate the influence of gender, age, and/or hormonal status on ER transcripts in a large population of human subjects.
